NO994902L - Forebygging av brystkreft ved selektive östrogenreseptormodulatorer - Google Patents
Forebygging av brystkreft ved selektive östrogenreseptormodulatorerInfo
- Publication number
- NO994902L NO994902L NO994902A NO994902A NO994902L NO 994902 L NO994902 L NO 994902L NO 994902 A NO994902 A NO 994902A NO 994902 A NO994902 A NO 994902A NO 994902 L NO994902 L NO 994902L
- Authority
- NO
- Norway
- Prior art keywords
- breast cancer
- estrogen receptor
- receptor modulators
- selective estrogen
- cancer prevention
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 3
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title 1
- 239000000333 selective estrogen receptor modulator Substances 0.000 title 1
- 229940095743 selective estrogen receptor modulator Drugs 0.000 title 1
- -1 pyrrolidino, methylpyrrolidino, dimethylpyrrolidino, piperidino, morpholino Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 201000008275 breast carcinoma Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Den foreliggende oppfinnelsen tilveiebringer en fremgangsmåte for forebygging av brystkarsinom eller kreft hos en pasient som innbefatter administrering av en terapeutisk effektiv mengde av en forbindelse som har strukturen (I) (O hvori R1 og R2 er uavhengig hydroksy eller alkoksy med en til fire karbonatomer; og R3 og R4 er uavhengig metyl eller etyl eller R3 og R4 sammen med nitrogenatomet som de er bundet til danner en pyrrolidino, metylpyrrolidino, dimetylpyrrolidino, piperidino, morfolino eller heksametylenimino ring.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4311897P | 1997-04-09 | 1997-04-09 | |
| PCT/US1998/006989 WO1998045286A1 (en) | 1997-04-09 | 1998-04-07 | Prevention of breast cancer with selective estrogen receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994902D0 NO994902D0 (no) | 1999-10-08 |
| NO994902L true NO994902L (no) | 1999-12-07 |
Family
ID=21925594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994902A NO994902L (no) | 1997-04-09 | 1999-10-08 | Forebygging av brystkreft ved selektive östrogenreseptormodulatorer |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0975628A4 (no) |
| JP (1) | JP2001518897A (no) |
| KR (1) | KR20010006215A (no) |
| CN (1) | CN1259945A (no) |
| AU (1) | AU6957398A (no) |
| CA (1) | CA2286207A1 (no) |
| EA (1) | EA199900910A1 (no) |
| HU (1) | HUP0001845A2 (no) |
| ID (1) | ID23653A (no) |
| IL (1) | IL132279A0 (no) |
| NO (1) | NO994902L (no) |
| PL (1) | PL336206A1 (no) |
| TR (1) | TR199903244T2 (no) |
| WO (1) | WO1998045286A1 (no) |
| ZA (1) | ZA982818B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610706B1 (en) | 1999-07-29 | 2003-08-26 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| US6653479B1 (en) | 1999-07-29 | 2003-11-25 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride |
| BRPI0818637A2 (pt) | 2007-10-16 | 2015-04-07 | Repros Therapeutics Inc | Métodos de tratamento de sintoma da síndrome metabólica, de glicose em jejum prejudicada, da síndrome metabólica e de redução de níveis de glicose em, jejum em sujeito com hipogonadismo hipogonadotrófico secundário ou idiopático |
| JP2015508825A (ja) | 2012-02-29 | 2015-03-23 | レプロス セラピューティクス インコーポレイティド | アンドロゲン欠乏症を治療するための併用療法 |
| ES2671516T3 (es) | 2013-02-19 | 2018-06-06 | Novartis Ag | Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógeno |
| GB201311888D0 (en) * | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| EP3373967B9 (en) | 2015-11-10 | 2023-10-04 | Paracrine Therapeutics AB | Treatment of er-negative breast cancer with an pdgf-cc inhibitor and an anti estrogen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5510357A (en) * | 1995-02-28 | 1996-04-23 | Eli Lilly And Company | Benzothiophene compounds as anti-estrogenic agents |
| SG64896A1 (en) * | 1995-02-28 | 1999-05-25 | Lilly Co Eli | Benzothiophene compounds intermediates compositions and methods |
| US5731342A (en) * | 1996-02-22 | 1998-03-24 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
-
1998
- 1998-04-02 ZA ZA9802818A patent/ZA982818B/xx unknown
- 1998-04-07 ID IDW991189A patent/ID23653A/id unknown
- 1998-04-07 KR KR1019997009295A patent/KR20010006215A/ko not_active Withdrawn
- 1998-04-07 TR TR1999/03244T patent/TR199903244T2/xx unknown
- 1998-04-07 EA EA199900910A patent/EA199900910A1/ru unknown
- 1998-04-07 CN CN98805957A patent/CN1259945A/zh active Pending
- 1998-04-07 WO PCT/US1998/006989 patent/WO1998045286A1/en not_active Ceased
- 1998-04-07 EP EP98915368A patent/EP0975628A4/en not_active Withdrawn
- 1998-04-07 IL IL13227998A patent/IL132279A0/xx unknown
- 1998-04-07 JP JP54309098A patent/JP2001518897A/ja active Pending
- 1998-04-07 PL PL98336206A patent/PL336206A1/xx unknown
- 1998-04-07 HU HU0001845A patent/HUP0001845A2/hu unknown
- 1998-04-07 CA CA002286207A patent/CA2286207A1/en not_active Abandoned
- 1998-04-07 AU AU69573/98A patent/AU6957398A/en not_active Abandoned
-
1999
- 1999-10-08 NO NO994902A patent/NO994902L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO994902D0 (no) | 1999-10-08 |
| CA2286207A1 (en) | 1998-10-15 |
| HUP0001845A2 (hu) | 2001-06-28 |
| EP0975628A4 (en) | 2001-03-21 |
| WO1998045286A1 (en) | 1998-10-15 |
| EP0975628A1 (en) | 2000-02-02 |
| EA199900910A1 (ru) | 2000-04-24 |
| KR20010006215A (ko) | 2001-01-26 |
| JP2001518897A (ja) | 2001-10-16 |
| ZA982818B (en) | 1999-10-04 |
| TR199903244T2 (xx) | 2000-05-22 |
| CN1259945A (zh) | 2000-07-12 |
| ID23653A (id) | 2000-05-11 |
| AU6957398A (en) | 1998-10-30 |
| IL132279A0 (en) | 2001-03-19 |
| PL336206A1 (en) | 2000-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO994901L (no) | Behandling av sentralnerveforstyrrelser ved selektive östrogenreseptormodulatorer | |
| DE69523169D1 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
| HUP0001192A2 (hu) | Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására | |
| LU93229I2 (fr) | "pitolisant et ses sels pharmaceutiquement acceptables, tel que chlorhydrate" | |
| MX9800577A (es) | Derivados de 4,5-diaril oxazol. | |
| DE69516866D1 (de) | Stereochemische wortmanninderivate | |
| ATE211732T1 (de) | N-benzylpiperidin- und tetrahydropyridin-derivate | |
| DK166383C (da) | N-phenyl-benzamidderivater, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse | |
| NO922380L (no) | Substituerte 4-fenyl-4-piperidinkarboksamider med baade lokal anestetisk og analgetisk effekt samt fremgangsmaater for deres fremstilling | |
| NO304379B1 (no) | 11,21-bisfenyl-19-norpregnan-derivater, anvendelse derav og farmas°ytiske preparater inneholdende slike derivater | |
| NZ313185A (en) | 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives | |
| NO942952L (no) | 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike | |
| GB9718903D0 (en) | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
| ES2123546T3 (es) | Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras. | |
| BR0011865A (pt) | derivados aromáticos e heterocìclicos de fitoteróis e/ou fitostanóis para uso no tratamento e prevenção de doença cardiovascular | |
| NO994902L (no) | Forebygging av brystkreft ved selektive östrogenreseptormodulatorer | |
| NO994903L (no) | Behandling eller profylakse av prostatakreft og benign prostatahyperplasi med selektive östrogenreseptormodulatorer | |
| PT71949A (en) | Process for the preparation of new derivatives of 6,7-benzomorphan having pharmaceutical effect | |
| TR199900286A2 (xx) | Pirolidin ve piperidin t�revleri. | |
| NO983444L (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer | |
| IL100955A (en) | Amino-polyhydroxy- cyclopentane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| NO975560L (no) | Fremgangsmåte for å redusere bentap | |
| HUP9904402A2 (hu) | Polihidroxi-fenol-származékok, alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |